Chico's FAS Statistics
Total Valuation
HGYN has a market cap or net worth of 2.52 million. The enterprise value is 2.60 million.
| Market Cap | 2.52M |
| Enterprise Value | 2.60M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
HGYN has 74.64 million shares outstanding.
| Current Share Class | 74.64M |
| Shares Outstanding | 74.64M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.18 |
| PB Ratio | -19.28 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -175.47 |
| EV / Sales | 5.33 |
| EV / EBITDA | 57.29 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.55
| Current Ratio | 0.55 |
| Quick Ratio | 0.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | 0.83 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 7.34% |
| Revenue Per Employee | 48,664 |
| Profits Per Employee | -1,479 |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HGYN has paid 3,090 in taxes.
| Income Tax | 3,090 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +111.25% in the last 52 weeks. The beta is 4.01, so HGYN's price volatility has been higher than the market average.
| Beta (5Y) | 4.01 |
| 52-Week Price Change | +111.25% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 65.23 |
| Average Volume (20 Days) | 4,910 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, HGYN had revenue of 486,637 and -14,790 in losses. Loss per share was -0.00.
| Revenue | 486,637 |
| Gross Profit | 209,615 |
| Operating Income | -9,607 |
| Pretax Income | -9,436 |
| Net Income | -14,790 |
| EBITDA | -8,255 |
| EBIT | -9,607 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 33,300 in cash and 37,713 in debt, giving a net cash position of -4,413 or -0.00 per share.
| Cash & Cash Equivalents | 33,300 |
| Total Debt | 37,713 |
| Net Cash | -4,413 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -130,826 |
| Book Value Per Share | -0.00 |
| Working Capital | -168,763 |
Cash Flow
| Operating Cash Flow | -63,805 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 43.07%, with operating and profit margins of -1.97% and -3.04%.
| Gross Margin | 43.07% |
| Operating Margin | -1.97% |
| Pretax Margin | -1.94% |
| Profit Margin | -3.04% |
| EBITDA Margin | -1.70% |
| EBIT Margin | -1.97% |
| FCF Margin | n/a |
Dividends & Yields
HGYN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -0.59% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HGYN has an Altman Z-Score of -557.94. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -557.94 |
| Piotroski F-Score | n/a |